Muzolimine
Muzolimine is a loop diuretic that was historically used to manage fluid retention (oedema) associated with conditions such as congestive heart failure and kidney disorders. It works by inhibiting sodium and chloride reabsorption in the kidneys, increasing the excretion of water and electrolytes through urine. Muzolimine was developed as an oral diuretic, although its current commercial availability and regulatory status are limited or uncertain in many countries. Potential adverse effects include dehydration, low blood pressure, electrolyte imbalances, and changes in kidney function. Excessive diuresis may cause disturbances in sodium and potassium levels, requiring careful clinical assessment. Its use should be considered only under specialist medical supervision, with confirmation of local availability and appropriate monitoring.
Muzolimine was historically used as a respiratory medicine for the symptomatic management of certain respiratory conditions. Its former uses included:
is okay
The import of medicines into India is regulated by the Central Drugs Standard Control Organisation (CDSCO) under the Drugs and Cosmetics Act, 1940, and the Drugs and Cosmetics Rules, 1945. The regulatory requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished formulation, or an unapproved medicine intended for an individual patient's treatment.
Primeera Healthcare Private Limited can provide import coordination and pharmaceutical documentation assistance for Muzolimine, subject to confirmation of its current regulatory status and eligibility for import into India.
The export of Muzolimine from India is subject to applicable requirements under the Drugs and Cosmetics Act, 1940, the Drugs and Cosmetics Rules, 1945, and relevant export, customs, and destination-country regulations. Documentation requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished pharmaceutical formulation, or a medicine intended for a specific market. Export eligibility and destination-country requirements must be verified before shipment.
Primeera Healthcare Private Limited can provide pharmaceutical export documentation assistance, regulatory coordination, and shipping support for Muzolimine, subject to confirmation of its export eligibility under applicable Indian regulations and the import requirements of the destination country.
If you have any questions or need any help, contact our Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
All Trademarks and Brands that appear on the website belong to their respective owners. Primeera Healthcare does not lay any claim on them; we only provide information.
